Study to Evaluate the Safety and Efficacy of Alefacept (Amevive) in Subjects With Moderate to Severe Atopic Dermatitis
Status:
Completed
Trial end date:
2009-10-01
Target enrollment:
Participant gender:
Summary
This study will assess the safety, tolerability, and efficacy of Alefacept in patient with
moderate to severe atopic dermatitis who could not be adequately controlled with topical
therapies.